BRCA2 and cancer: To address whether these cancer mutations impact on the function of BRCA2, we investigated the cell viability and DNA damage tolerance of cells expressing BRCA2 S1106R, T1116P, and T1128I in our RNAi and complementation system in U2OS Flp-In T-REx cells (Supplementary Fig. 6c).